Aberdeen Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,394
| Closed | -$203K | – | 1071 |
|
|
2021
Q3 | $203K | Sell |
1,394
-42
| -3% | -$6.12K | ﹤0.01% | 1034 |
|
|
2021
Q2 | $281K | Sell |
1,436
-1,019
| -42% | -$199K | ﹤0.01% | 985 |
|
|
2021
Q1 | $444K | Buy |
2,455
+263
| +12% | +$47.6K | ﹤0.01% | 921 |
|
|
2020
Q4 | $310K | Sell |
2,192
-1,633
| -43% | -$231K | ﹤0.01% | 921 |
|
|
2020
Q3 | $477K | Buy |
+3,825
| New | +$477K | ﹤0.01% | 851 |
|
|
2020
Q2 | – | Sell |
-3,958
| Closed | -$247K | – | 941 |
|
|
2020
Q1 | $247K | Buy |
+3,958
| New | +$247K | ﹤0.01% | 886 |
|